QEII Health Sciences Centre (Dalhousie University)
Halifax, Nova Scotia, Canada
Medical laboratory in Halifax, Nova Scotia
5788 University Ave, Halifax, NS B3H 1V8
About QEII Health Sciences Centre (Dalhousie University)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
4
DePuy Orthopaedics
2
Clinical Trials at QEII Health Sciences Centre (Dalhousie University)
During the past decade, QEII Health Sciences Centre (Dalhousie University) conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on
average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Roll Over Study From 1199.30 BIBF 1120 in Idiopathic Pulmonary Fibrosis (IPF)
2010-06-25
2016-09-26
Completed
198
Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)
2013-11-26
2016-10-27
Completed
113
Efficacy and Safety of Nintedanib Co-administered With Sildenafil in Idiopathic Pulmonary Fibrosis Patients With Advanced Lung Function Impairment
2016-06-30
2018-04-13
Completed
274
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at QEII Health Sciences Centre (Dalhousie University)
According to Clinical.Site data, the most researched conditions in "QEII Health Sciences Centre (Dalhousie University)" are
"Degenerative Arthritis" (2 trials), "Idiopathic Pulmonary Fibrosis" (2 trials), "Osteoarthritis" (2 trials), "Mesothelioma" (1 trials) and "Pulmonary Fibrosis" (1 trials). Many other conditions were trialed in "QEII Health Sciences Centre (Dalhousie University)" in a lesser frequency.
Clinical Trials Intervention Types at QEII Health Sciences Centre (Dalhousie University)
Most popular intervention types in "QEII Health Sciences Centre (Dalhousie University)" are "Drug" (4 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "Nintedanib" (3 trials), "Placebo" (2 trials), "BIBF 1120" (1 trials), "Cisplatin" (1 trials) and "Matching Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at QEII Health Sciences Centre (Dalhousie University)
The vast majority of trials in "QEII Health Sciences Centre (Dalhousie University)" are
6 trials for "All" genders.
Clinical Trials Status at QEII Health Sciences Centre (Dalhousie University)
Currently, there are NaN active trials in "QEII Health Sciences Centre (Dalhousie University)".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in QEII Health Sciences Centre (Dalhousie University),
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in QEII Health Sciences Centre (Dalhousie University), 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".